OVERVIEW
Cirrus' proven approach to contract drug
product development moves our clients' compounds through the
development process quickly and efficiently. Resources exist
to develop a broad range of traditional dosage forms (e.g.,
injectable, oral and topical products), as well as novel drug
delivery systems (e.g., inhalation, intranasal or novel protein
delivery). Cirrus offers extensive expertise in the development
of aerosol products, including Metered Dose Inhalers (MDI),
Dry Powder Inhalers (DPI), nasal sprays and solutions for
nebulization.
The team-oriented environment at Cirrus
provides responsive, reliable, and integrated services for
research, product development, and laboratory testing. To
focus on our core strengths, we build collaborative partnerships
with qualified subcontractors to offer an extensive menu of
services.
Whether for full-scale product development
or release testing of a marketed product, Cirrus can meet
the requirements.
|